Management of Bronchiectasis

Disease-a-Month

Volumn 54, Issue 8, 2008, Pages 540-546

  Kim, Daniel N ^a   Lazarus, Angeline A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CORTICOSTEROID; DEOXYRIBONUCLEASE; IBUPROFEN; MACROLIDE; MANNITOL; MUCOLYTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM CHLORIDE; TOBRAMYCIN;

BRONCHIECTASIS; COUGHING; DISEASE EXACERBATION; DYSPNEA; EXERCISE TOLERANCE; FATIGUE; FEVER; HAEMOPHILUS INFLUENZAE; HEMOPTYSIS; HUMAN; LETHARGY; LUNG FUNCTION; LUNG TRANSPLANTATION; MALAISE; PHYSIOTHERAPY; POSTURAL DRAINAGE; PSEUDOMONAS AERUGINOSA; REVIEW; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SURGICAL TECHNIQUE; THORACOTOMY; THORAX RADIOGRAPHY; WHEEZING;

ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; BRONCHODILATOR AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PNEUMONIA; PROGNOSIS; PULMONARY SURGICAL PROCEDURES; RESPIRATORY THERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 47049130145     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.05.003     Document Type: Review

References (30)

1. Barker A.F. Bronchiectasis. N Engl J Med 346 (2002) 1383-1393
2. O'Donnell A.E., Barker A.F., Ilowite J.S., et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest 113 (1998) 1329-1334
3. Pang J.A., Cheng A., Chan D., et al. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis 139 (1989) 14-17
4. Angrill J., Agusti C., de Celis R., et al. Bacterial colonization in patients with bronchitectasis: microbial pattern and risk factors. Thorax 57 (2002) 15-19
5. Ramsey B.W., Pepe M.S., Quan J.M., et al. Intermittent Administration of Inhaled Tobramycin in patients with cystic fibrosis. New Engl J Med 340 (1999) 23-30
6. Bilton D., Henig N., Morrissey B., et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 130 (2006) 1503-1510
7. Ferkol T., Rosenfeld M., and Milla C.E. Cystic fibrosis pulmonary exacerbations. J Pediatr 148 (2006) 259-264
8. Wilson C.B., Jones P.W., O'Leary C.J., et al. Effect of sputum bacteriology on the quality of life of patient with bronchiectasis. Eur Respir J 10 (1997) 1754-1760
9. Ho P.L., Chan K.N., Ip M.S.M., et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 114 (1998) 1594-1598
10. Rayner C.F., Tillotson G., Cole P.J., et al. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother 34 (1994) 149-156
11. Evans D.J., Bara A.I., and Greenstone M. Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database of Systematic Reviews 2 (2007) CD001392. DOI:10.1002/14651858.CD001392.pub2
12. Saiman L., Marshall B.C., Mayer-Hamblett N., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. JAMA 290 (2003) 1749-1756
13. Davies G., and Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithormycin. Thorax 59 (2004) 540-541
14. Barker A.F., Couch L., Fiel S.B., et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 162 (2000) 481-485
15. McCool F.D., and Rosen M.J. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest 129 suppl (2006) 250S-259S
16. Wills P., and Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2 (2006) CD002996
17. Daviskas E., Anderson S.D., Eberl S., et al. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med 159 (1999) 1843-1848
18. Rosen M.J. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest 129 suppl (2006) 122S-131S
19. Tsang K.W., Tan K.C., Ho P.L., et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 60 (2005) 239-243
20. Kolbe J., Wells A., and Ram F.S. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev 2 (2000) CD000996
21. Tsang K.W., Ho P.L., Lam W.K., et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 158 (1998) 723-727
22. Balkanli K., Genc O., Dakak M., et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg 24 (2003) 699-702
23. Yankaskas J.R., Mallory Jr. G.B., and Consensus Committee. Lung transplantation in cystic fibrosis: consensus conference statement. Chest 113 (1998) 217-226
24. Beirne P.A., Banner N.R., Khaghani A., et al. Lung transplant for non-cystic fibrosis bronchiectasis: analysis of a 13-year experience. J Heart Lung Transplant 24 (2005) 1530-1535
25. Flume P.A., Yankaskas J.R., Ebeling M., et al. Massive hemoptysis in cystic fibrosis. Chest 128 (2005) 729-738
26. McGuinness G., Beacher J.R., Harkin T.J., et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 105 (1994) 1155-1162
27. Mal H., Rullon I., Mellot F., et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 115 (1999) 996-1001
28. Fujimoto T., Hillejan L., and Stamatis G. Current strategy for surgical management of bronchiectasis. Ann Thorac Surg 72 (2001) 1711-1715
29. Li A.M., Sonnappa S., Lex C., et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J 26 (2005) 8-14
30. Elborn J.S., and Bell S.C. Pulmonary exacerbations in cystic fibrosis and bronchiectasis. Thorax 62 (2007) 288-290